Akebia Therapeutics (AKBA) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.04
-0.02
0.01
0.03

Details

Expected EPS
-0.028
Actual EPS
-0.03
Surprise EPS
-0
Surprise Percent
-7.14%

Description

⁨Akebia Therapeutics⁩ (⁦AKBA⁩) has reported earnings of ⁦-0.03⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts